Cerecor Inc. Contracts & Agreements
143 Contracts & Agreements
- Business Finance (69 contracts)
- Business Operations (6)
- Human Resources (31)
- Intellectual Property (11)
- Mergers & Acquisitions (5)
- Real Estate (2)
- Uncategorized (19)
- Non-Employee Director Compensation Policy, Amended June 6, 2024 with an effective date of July 1, 2024 (Filed With SEC on November 7, 2024)
- Avalo Therapeutics, Inc. Fo (Filed With SEC on August 14, 2024)
- Avalo Therapeutics, Inc (Filed With SEC on August 14, 2024)
- Employment Agreement, dated (Filed With SEC on July 16, 2024)
- Employment Agreement, dated May 6, 2024, by and between Avalo Therapeutics, Inc. and Paul Varki (Filed With SEC on June 24, 2024)
- Amendment to Employment Agreement, Dated May 10, 2024, by and between Avalo Therapeutics, Inc. and Paul Varki (Filed With SEC on June 24, 2024)
- Asset Purchase Agreement, dated December 6, 2023, by and among AlmataBio, Inc., Leap Therapeutics, Inc., and Flame Biosciences LLC (Filed With SEC on May 13, 2024)
- License Agreement by, dated November 25, 2019, by and between Flame Biosciences LLC and Eli Lilly and Company (Filed With SEC on May 13, 2024)
- First Amendment to License Agreement, dated (Filed With SEC on May 13, 2024)
- Agreement and Plan of Merger and Reorganization, dated March (Filed With SEC on March 28, 2024)
- Form of Warrant (Filed With SEC on March 28, 2024)
- Securities Purchase Agreement, dated March (Filed With SEC on March 28, 2024)
- Registration Rights Agreement (Filed With SEC on March 28, 2024)
- Payoff Letter, dated as of September 22, 2023, between Avalo Therapeutics, Inc. and Horizon Credit II LLC, Horizon Funding Trust 2019-1, Horizon Funding I, LLC, Powerscourt... (Filed With SEC on September 26, 2023)
- Third Forbearance Agreement, dated as of September (Filed With SEC on September 13, 2023)
- First Amendment to Loan Agreement, dated as of September 13, 2023, between Avalo Therapeutics, Inc. and Horizon Credit II LLC, Horizon Funding Trust 2019-1, Horizon Funding I,... (Filed With SEC on September 13, 2023)
- Purchase Agreement, dated September 11, 2023, by and between AUG Therapeutics, LLC and Avalo Therapeutics, Inc (Filed With SEC on September 12, 2023)
- Second Forbearance Agreement, dated as of August 14, 2023, between Avalo Therapeutics, Inc. and Horizon Credit II LLC, Horizon Funding Trust 2019-1, Horizon Funding I, LLC,... (Filed With SEC on August 14, 2023)
- Amendment No. 1 to the Sales Agreement, dated as of August (Filed With SEC on August 7, 2023)
- Forbearance Agreement, dated as of July (Filed With SEC on July 21, 2023)
- Form of Exchange Warrant (Filed With SEC on June 2, 2023)
- Exchange Agreement, dated as of (Filed With SEC on June 2, 2023)
- Sales Agreement, dated as of May (Filed With SEC on May 4, 2023)
- Underwriting Agreement, dated February 2, 2023, between Avalo Therapeutics, Inc., SVB Securities LLC and RBC Capital Markets, LLC, as representatives of the several underwriters... (Filed With SEC on February 3, 2023)
- Form of Warrant (Filed With SEC on February 3, 2023)
- License Agreement, dated July 29, 2022, by and between Apollo AP43 Limited and Avalo Therapeutics, Inc (Filed With SEC on November 7, 2022)
- Purchase Agreement, dated November 4, 2022, by and between ES Therapeutics, LLC and Avalo Therapeutics, Inc (Filed With SEC on November 7, 2022)
- Waiver, dated August (Filed With SEC on August 11, 2022)
- Description of Registered Securities (Filed With SEC on March 2, 2022)
- Non-Employee Director Compensation Policy, amended January (Filed With SEC on March 2, 2022)
- Letter Agreement, dated February 18, 2022, by and between Avalo Therapeutics, Inc. and Garry Neil (Filed With SEC on February 18, 2022)
- Letter Agreement, dated February (Filed With SEC on February 18, 2022)
- Cooperation Agreement, dated as of November 4, 2021, by and between Avalo Therapeutics, Inc. and Armistice Capital, LLC (Filed With SEC on November 9, 2021)
- Underwriting Agreement, dated September (Filed With SEC on September 15, 2021)
- Exclusive Patent License Agreement, dated June 22, 2021, by and between Sanford Burnham Prebys Medical Discovery Institute and Cerecor Inc (Filed With SEC on August 2, 2021)
- Loan Agreement, dated June 4, 2021, by and between Horizon Technology Finance Corporation, Powerscourt Investments XXV, LP and Cerecor Inc (Filed With SEC on August 2, 2021)
- Amendment No (Filed With SEC on August 2, 2021)
- Controlled Equity Offering (Filed With SEC on July 2, 2021)
- Warrant to Purchase Common Stock (Loan A) issued (Filed With SEC on June 8, 2021)
- Warrant to Purchase Common Stock (Loan B) issued (Filed With SEC on June 8, 2021)
- Warrant to Purchase Common Stock (Loan C) issued (Filed With SEC on June 8, 2021)
- Warrant to Purchase Common Stock (Loan D) issued (Filed With SEC on June 8, 2021)
- Warrant to Purchase Common Stock (Loan E) issued (Filed With SEC on June 8, 2021)
- Warrant to Purchase Common Stock (Loan F) issued (Filed With SEC on June 8, 2021)
- Warrant to Purchase Common Stock (Loan G) issued (Filed With SEC on June 8, 2021)
- Warrant to Purchase Common Stock (Loan H) issued (Filed With SEC on June 8, 2021)
- License Agreement, dated March 25, 2021, by and between Cerecor Inc. and Kyowa Hakko Kirin Co., Ltd (Filed With SEC on May 13, 2021)
- Description of Registered Securities (Filed With SEC on March 8, 2021)
- Offer Letter, dated February 19, 2020, from Cerecor Inc. to H. Jeffrey Wilkins, M.D (Filed With SEC on March 8, 2021)
- Employment Agreement, dated February 10, 2021, by and between Cerecor Inc. and Schond L. Greenway (Filed With SEC on March 1, 2021)
- Stock Option Agreement, dated (Filed With SEC on March 1, 2021)
- Underwriting Agreement, dated January 7, 2021, by and between Cerecor Inc. and Jefferies LLC (Filed With SEC on January 8, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on January 8, 2021)
- Amendment No. 6 to License Agreement, dated as of November 16, 2020, by and between Medgenics Medical Israel Ltd. and The Children's Hospital of Philadelphia (Filed With SEC on November 20, 2020)
- Amendment No. 6 to Sponsored Research Agreement, dated as of (Filed With SEC on November 20, 2020)
- Cerecor Inc. Third Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on June 18, 2020)
- Underwriting Agreement, dated June 9, 2020, by and between Cerecor Inc. and Oppenheimer & Co. Inc (Filed With SEC on June 9, 2020)
- Amendment to Employment Agreement, effective March 11, 2020, by and between Cerecor Inc. and Michael F. Cola (Filed With SEC on May 7, 2020)
- Employment Agreement, dated September 26, 2019, by and between Cerecor Inc. and Christopher Sullivan (Filed With SEC on April 27, 2020)
- Letter Agreement, dated April 23, 2020, by and between Cerecor Inc. and Christopher Sullivan (Filed With SEC on April 27, 2020)
- Separation Agreement, dated April 24, 2020, by and between Cerecor Inc. and Simon Pedder (Filed With SEC on April 27, 2020)
- Separation Agreement, dated March 25, 2020, by and between Cerecor Inc. and Pericles Calias (Filed With SEC on March 27, 2020)
- Securities Purchase Agreement, dated March 17, 2020, between Cerecor Inc. and the investor(s) named therein (Filed With SEC on March 18, 2020)
- Registration Rights Agreement, dated March 17, 2020, between Cerecor Inc. and the investor(s) named therein (Filed With SEC on March 18, 2020)
- Description of Registered Securities (Filed With SEC on March 11, 2020)
- Amendment to Employment Agreement of James A. Harrell, Jr., dated October 14, 2019 (Filed With SEC on March 11, 2020)
- Assignment of License Agreement, dated August 8, 2019, entered into by and between Cerecor Inc., ES Therapeutics, LLC, and Armistice Capital Master Fund Ltd (Filed With SEC on March 11, 2020)
- Form of Securities Purchase Agreement, dated February 3, 2020 (Filed With SEC on February 4, 2020)
- Contingent Value Rights Agreement, effective February 3, 2020, by and between Cerecor Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on February 3, 2020)
- Employment Agreement, effective February 3, 2020, by and between Cerecor Inc. and Michael F. Cola (Filed With SEC on February 3, 2020)
- Employment Agreement, effective February 3, 2020, by and between Cerecor Inc. and Garry A. Neil (Filed With SEC on February 3, 2020)
- Agreement and Plan of Merger and Reorganization, dated December 5, 2019, by and among Cerecor Inc., Genie Merger Sub, Inc., Second Genie Merger Sub LLC and Aevi Genomic Medicine,... (Filed With SEC on December 11, 2019)
- Agreement and Plan of Merger and Reorganization, dated December 5, 2019, by and among Cerecor Inc., Genie Merger Sub, Inc., Second Genie Merger Sub LLC and Aevi Genomic Medicine,... (Filed With SEC on December 5, 2019)
- Form of Contingent Value Rights Agreement by and between Cerecor Inc. and Rights Agent (Filed With SEC on December 5, 2019)
- Form of Voting Agreement, dated December 5, 2019, by and among Cerecor Inc., Aevi Genomic Medicine, Inc. and certain Holders named therein (Filed With SEC on December 5, 2019)
- Promissory Note for License Expenses, dated December 5, 2019, by and between Cerecor Inc. and Aevi Genomic Medicine, Inc (Filed With SEC on December 5, 2019)
- Promissory Note for Operating Expenses, dated December 5, 2019, by and between Cerecor Inc. and Aevi Genomic Medicine, Inc (Filed With SEC on December 5, 2019)
- Backstop Agreement, dated December 5, 2019, by and between Cerecor Inc. and Armistice Capital Master Fund Ltd (Filed With SEC on December 5, 2019)
- First Amendment to the Asset Purchase Agreement, dated November 1, 2019, by and between Cerecor Inc. and Aytu Bioscience, Inc (Filed With SEC on November 4, 2019)
- Guarantee dated November 1, 2019, by and between Cerecor Inc. and Deerfield CSF, LLC, Peter Steelman and James Flynn (Filed With SEC on November 4, 2019)
- Contribution Agreement, dated November 1, 2019, by and between Cerecor Inc., Armistice Capital Master Fund, Ltd. And Avadel US Holdings Inc (Filed With SEC on November 4, 2019)
- Securities Purchase Agreement, dated September 4, 2019, between Cerecor Inc. and the investor(s) named therein (Filed With SEC on September 9, 2019)
- Registration Rights Agreement, dated September 4, 2019, between Cerecor Inc. and the investor(s) named therein (Filed With SEC on September 9, 2019)
- Cerecor Inc. Second Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on August 8, 2019)
- Employment Agreement, dated April 10, 2019, by and between Cerecor Inc. and Simon Pedder (Filed With SEC on April 12, 2019)
- Amended and Restated Underwriting Agreement, dated March 6, 2019, between Cerecor Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 6, 2019)
- Exchanged Warrant issued to Armistice Capital Master Fund Ltd. on December 27, 2018 (Filed With SEC on December 27, 2018)
- New Warrant issued to Armistice Capital Master Fund Ltd. on December 27, 2018 (Filed With SEC on December 27, 2018)
- Securities Purchase Agreement, dated December 27, 2018, between Cerecor Inc. and Armistice Capital Master Fund Ltd (Filed With SEC on December 27, 2018)
- Registration Rights Agreement, dated December 27, 2018, between Cerecor Inc. and Armistice Capital Master Fund Ltd (Filed With SEC on December 27, 2018)
- Agreement and Plan of Merger, dated September 24, 2018, by and among Cerecor Inc., ITX Merger Sub, Inc., a direct wholly owned subsidiary of Cerecor Inc., Ichorion Therapeutics,... (Filed With SEC on September 26, 2018)
- Lease, dated September 14, 2018, by and between Cerecor Inc. and FP 540 Gaither, LLC (Filed With SEC on September 18, 2018)
- Securities Purchase Agreement, dated August 17, 2018, between Cerecor Inc. and the investor(s) named therein (Filed With SEC on August 20, 2018)
- Registration Rights Agreement, dated August 20, 2018, between Cerecor Inc. and the investor(s) named therein (Filed With SEC on August 20, 2018)
- Employment Agreement, dated July 12, 2018, by and between Cerecor Inc. and Joseph M. Miller (Filed With SEC on July 16, 2018)
- Separation and Release Agreement, dated July 13, 2018, by and between Cerecor Inc. and Mariam E. Morris (Filed With SEC on July 16, 2018)
- Employment Agreement, dated July 16, 2018, by and between Cerecor Inc. and Pericles Calias (Filed With SEC on July 16, 2018)
- Cerecor Inc. Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on May 17, 2018)
- Asset Purchase Agreement, dated February 12, 2018, by and between Cerecor Inc., Avadel US Holdings, Inc., Avadel Pharmaceuticals (USA), Inc., Avadel Pediatrics, Inc., Avadel... (Filed With SEC on May 11, 2018)
- License and Development Agreement, dated February 16, 2018, by and between Cerecor Inc. and Flamel Ireland Limited (Filed With SEC on May 11, 2018)
- Employment Agreement, dated April 23, 2018, by and between Cerecor Inc. and James A. Harrell, Jr (Filed With SEC on April 27, 2018)
- Separation and Release Agreement, dated April 23, 2018, by and between Cerecor Inc. and Robert Moscato (Filed With SEC on April 27, 2018)
- Employment Agreement, dated January 22, 2018, by and between Cerecor Inc. and Matthew Phillips (Filed With SEC on April 10, 2018)
- Employment Agreement by and between Cerecor Inc. and Robert C. Moscato, Jr., effective November 21, 2017 (Filed With SEC on April 2, 2018)
- Employment Agreement, dated March 27, 2018, by and between Cerecor Inc. and Peter Greenleaf (Filed With SEC on April 2, 2018)
- Equity Interest Purchase Agreement, dated November 17, 2017, by and among Cerecor Inc., TRx Pharmaceuticals, LLC, Fremantle Corporation and LRS International LLC, the selling... (Filed With SEC on November 17, 2017)
- Agreement and Plan of Merger and Reorganization, dated November 17, 2017, by and among Cerecor Inc., ZPC Merger Corp., a direct wholly owned subsidiary of Cerecor Inc., Zylera... (Filed With SEC on November 17, 2017)
- ASSET PURCHASE AGREEMENT Dated as of August 14, 2017 between JANSSEN PHARMACEUTICALS, INC. and CERECOR INC. (Filed With SEC on August 14, 2017)
- COMMON STOCK PURCHASE WARRANT CERECOR INC. (Filed With SEC on April 28, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 28, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 28, 2017)
- Cerecor Inc. Up to $12,075,338 Common Stock Equity Distribution Agreement (Filed With SEC on January 27, 2017)
- CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT by and between Eli Lilly and Company and CERECOR INC. Effective Date of September 08, 2016 (Filed With SEC on November 8, 2016)
- [Cerecor, Inc. Letterhead] (Filed With SEC on November 8, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 12, 2016)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on September 12, 2016)
- Cerecor, Inc. 2016 Equity Incentive Plan Adopted by the Board of Directors: April 5, 2016 Approved by the Stockholders: May 18, 2016 (Filed With SEC on May 20, 2016)
- Cerecor, Inc. 2016 Employee Stock Purchase Plan Adopted by the Board of Directors: April 5, 2016 Approved by the Stockholders: May 18, 2016 (Filed With SEC on May 20, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 23, 2016)
- CERECOR Inc. Non- Employee Director Compensation Policy Amended January 10, 2016 (Filed With SEC on March 23, 2016)
- Form of UPO (Filed With SEC on October 20, 2015)
- CERECOR INC. UNDERWRITING AGREEMENT (Filed With SEC on October 13, 2015)
- CLASS A WARRANT AGREEMENT (Filed With SEC on October 13, 2015)
- SPECIMEN CLASS A WARRANT CERTIFICATE NUMBER [ ] WARRANTS WA- (THIS WARRANT WILL BE VOID IF NOT EXERCISED PRIOR TO 5:00 P.M. NEW YORK CITY TIME, THIRTY-SIX MONTHS FROM THE CLOSING... (Filed With SEC on October 13, 2015)
- CLASS B WARRANT AGREEMENT (Filed With SEC on October 13, 2015)
- SPECIMEN CLASS B WARRANT CERTIFICATE (Filed With SEC on October 13, 2015)
- SPECIMEN UNIT CERTIFICATE (Filed With SEC on October 13, 2015)
- CERECOR INC. UNDERWRITING AGREEMENT (Filed With SEC on September 22, 2015)
- CERECOR INC. 2015 OMNIBUS INCENTIVE COMPENSATION PLAN (Filed With SEC on September 8, 2015)
- INDEMNIFICATION AGREEMENT (Filed With SEC on September 8, 2015)
- Director Indemnification Agreements (Filed With SEC on September 8, 2015)
- SIGNATURE PAGE TO INVESTORS' RIGHTS AGREEMENT (Filed With SEC on June 12, 2015)
- COMMON STOCK WARRANT CERECOR INC. (Filed With SEC on June 12, 2015)
- SIGNATURE PAGE TO CERECOR INC. AMENDMENT TO COMMON STOCK WARRANTS (Filed With SEC on June 12, 2015)
- COMMON STOCK WARRANT CERECOR INC. (Filed With SEC on June 12, 2015)
- COMMON STOCK WARRANT CERECOR INC. (Filed With SEC on June 12, 2015)
- EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT by and between ESSEX CHEMIE AG and CERECOR INC. (Filed With SEC on June 12, 2015)
- EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT by and between ESSEX CHEMIE AG and CERECOR INC. (Filed With SEC on June 12, 2015)
- CERECOR INC. 2011 STOCK INCENTIVE PLAN ARTICLE I PURPOSE (Filed With SEC on June 12, 2015)
- Cerecor Inc. 75 Rockefeller Plaza, 29thFloor New York, NY 10019 (Filed With SEC on June 12, 2015)
- Cerecor CONSULTING AND INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on June 12, 2015)
- CERECOR INC. (Filed With SEC on June 12, 2015)
- LEASE AGREEMENT (Filed With SEC on June 12, 2015)
